1. Home
  2. OSBC vs IMNM Comparison

OSBC vs IMNM Comparison

Compare OSBC & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSBC
  • IMNM
  • Stock Information
  • Founded
  • OSBC 1981
  • IMNM 2006
  • Country
  • OSBC United States
  • IMNM United States
  • Employees
  • OSBC N/A
  • IMNM N/A
  • Industry
  • OSBC Major Banks
  • IMNM Medicinal Chemicals and Botanical Products
  • Sector
  • OSBC Finance
  • IMNM Health Care
  • Exchange
  • OSBC Nasdaq
  • IMNM Nasdaq
  • Market Cap
  • OSBC 708.1M
  • IMNM 687.8M
  • IPO Year
  • OSBC N/A
  • IMNM 2020
  • Fundamental
  • Price
  • OSBC $16.59
  • IMNM $7.46
  • Analyst Decision
  • OSBC Buy
  • IMNM Strong Buy
  • Analyst Count
  • OSBC 5
  • IMNM 5
  • Target Price
  • OSBC $20.00
  • IMNM $26.40
  • AVG Volume (30 Days)
  • OSBC 228.8K
  • IMNM 1.1M
  • Earning Date
  • OSBC 04-23-2025
  • IMNM 05-16-2025
  • Dividend Yield
  • OSBC 1.43%
  • IMNM N/A
  • EPS Growth
  • OSBC N/A
  • IMNM N/A
  • EPS
  • OSBC 1.83
  • IMNM N/A
  • Revenue
  • OSBC $275,720,000.00
  • IMNM $9,041,000.00
  • Revenue This Year
  • OSBC $17.44
  • IMNM N/A
  • Revenue Next Year
  • OSBC $14.38
  • IMNM $1,259.12
  • P/E Ratio
  • OSBC $9.16
  • IMNM N/A
  • Revenue Growth
  • OSBC 2.88
  • IMNM N/A
  • 52 Week Low
  • OSBC $13.27
  • IMNM $5.15
  • 52 Week High
  • OSBC $19.46
  • IMNM $19.07
  • Technical
  • Relative Strength Index (RSI)
  • OSBC 60.17
  • IMNM 43.56
  • Support Level
  • OSBC $15.53
  • IMNM $7.15
  • Resistance Level
  • OSBC $16.95
  • IMNM $9.16
  • Average True Range (ATR)
  • OSBC 0.59
  • IMNM 0.51
  • MACD
  • OSBC 0.19
  • IMNM -0.08
  • Stochastic Oscillator
  • OSBC 82.53
  • IMNM 15.42

About OSBC Old Second Bancorp Inc.

Old Second Bancorp Inc is a bank holding company. It provides consumer and commercial banking products such as demand, money market, savings, time deposit, and individual retirement as well as commercial, industrial, consumer, and real estate lending, including installment loans, student loans, agricultural loans, lines of credit and overdraft checking, safe deposit operations, trust services, wealth management services, and additional services tailored to the needs of individual customers, corporates, small-medium enterprises. The Company has one operating segment, which is community banking. The company's revenue consists of interest, commission, payments, and other income.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: